Replies to post #5002 on Ariad Pharmaceuticals Inc fka ARIA

[BTH]

I agree.
I think for all holders of Ariad, this is when Ariad's officially "turned the corner".

They have a proven drug, and a "stable" of compounds which could be blockbuster status - and if you throw in the other indications for which Ridaforolimus could be used in combination, the company is a solid company now.

Personally, I think with all the potential indications in Rida and the promise of Ponatinib, this stock should be carrying a value equivalent to Incyte.

Gotta be a viable takeover speculative candidate now, too. IMO, once the flippers and profit-takers are gone over the next week, barring a catastrophe in the overall markets, this stock is heading into the mid-teens.